KL-6

image not found

NABL Cap Accredited    
KL-6 is a serum biomarker used to evaluate interstitial lung diseases (ILD) and other pulmonary conditions involving alveolar epithelial cell damage. Elevated KL-6 levels indicate active lung injury or fibrosis and can help monitor disease progression and response to treatment. This test is particularly useful for patients with idiopathic pulmonary fibrosis, connective tissue disease-associated ILD, or drug-induced lung injury. Metropolis Healthcare performs KL-6 testing using sensitive immunoassay techniques to provide accurate and clinically actionable results

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,000.00

Sample Type: SERUM

Fasting Not Required


Notes: K8510

Frequently Asked Questions (FAQ's):

What does the KL-6 test detect?
It measures KL-6 protein levels, reflecting alveolar epithelial cell damage in interstitial lung disease.

Who should undergo this test?
Patients with suspected or diagnosed ILD, pulmonary fibrosis, or unexplained respiratory symptoms.

Is fasting required?
Fasting is generally not required.

What sample is needed?
A serum sample collected from a blood draw.

How does Metropolis Healthcare perform this test?
Using high-sensitivity immunoassays for precise measurement of KL-6 levels.

Can medications affect KL-6 levels?
Certain treatments or anti-fibrotic therapies may influence KL-6 concentration.

How are the results used?

To assess disease activity, monitor treatment response, and support prognosis in lung disease patients 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab